A review of the pharmacoeconomics of eletriptan for the acute treatment of migraine

References

• Headache Classification Committee of the International Headache Society (IHS)The International Classification of Headache Disorders, 3rd edition (beta version)Cephalalgia201333962980823771276
   PubMed Web of Science ®Google Scholar
• LiptonRBScherAIKolodnerKLibermanJSteinerTJStewartWFMigraine in the United States: epidemiology and patterns of health care useNeurology200258688589411914403
   PubMed Web of Science ®Google Scholar
• McCormackPLKeatingGMEletriptan: a review of its use in the acute treatment of migraineDrugs20066681129114916789799
   PubMed Web of Science ®Google Scholar
• LiptonRBBigalMEDiamondMFreitagFReedMLStewartWFAMPP Advisory GroupMigraine prevalence, disease burden, and the need for preventive therapyNeurology200768534334917261680
   PubMed Web of Science ®Google Scholar
• Von KorffMStewartWFSimonDJLiptonRBMigraine and reduced work performance: a population-based diary studyNeurology1998506174117459633720
   PubMed Web of Science ®Google Scholar
• LiptonRBDiamondSReedMDiamondMLStewartWFMigraine diagnosis and treatment: results from the American Migraine Study IIHeadache200141763864511554951
   PubMed Web of Science ®Google Scholar
• BuseDCLiptonRBGlobal perspectives on the burden of episodic and chronic migraineCephalalgia2013331188589023482725
   PubMed Web of Science ®Google Scholar
• GoldsteinJTiseoPTAlbertKSLiCSikesCREletriptan in migraine patients reporting unsatisfactory response to rizatriptanHeadache20064671142115016866718
   PubMed Web of Science ®Google Scholar
• AukermanGKnutsonDMiserWFDepartment of Family Medicine, Ohio State University College of Medicine and Public Health, Columbus, OhioManagement of the acute migraine headacheAm Fam Physician200266112123213012484694
   PubMed Web of Science ®Google Scholar
• OlesenJBursteinRAshinaMTfelt-HansenPOrigin of pain in migraine: evidence for peripheral sensitisationLancet Neurol20098767969019539239
   PubMed Web of Science ®Google Scholar
• CaroJJGetsiosDPharmacoeconomic evidence and considerations for triptan treatment of migraineExpert Opin Pharmacother20023323724811866674
   PubMedGoogle Scholar
• AsseburgCPeuraPOksanenTTurunenJPurmonenTMartikainenJCost-effectiveness of oral triptans for acute migraine: mixed treatment comparisonInt J Technol Assess Health Care201228438238923013610
   PubMed Web of Science ®Google Scholar
• LambCERatnerPHJohnsonCEEconomic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspectiveCurr Med Res Opin20062261203121016846553
   PubMed Web of Science ®Google Scholar
• LiptonRBStewartWFScherAIEpidemiology and economic impact of migraineCurr Med Res Opin200117Suppl 1S4S1212463270
   PubMedGoogle Scholar
• StangPEOsterhausJTImpact of migraine in the United States: data from the National Health Interview SurveyHeadache199333129358436495
   PubMed Web of Science ®Google Scholar
• de LissovoyGLazarusSSThe economic cost of migraine. Present state of knowledgeNeurology1994446 Suppl 4S56S628008226
   PubMed Web of Science ®Google Scholar
• DuelandANLeiraRBurkeTAHillyerEVBolgeSThe impact of migraine on work, family, and leisure among young women – a multinational studyCurr Med Res Opin200420101595160415462692
   PubMed Web of Science ®Google Scholar
• HuXHMarksonLELiptonRBStewartWFBergerMLBurden of migraine in the United States: disability and economic costsArch Intern Med1999159881381810219926
   PubMed Web of Science ®Google Scholar
• LindeMGustavssonAStovnerLJThe cost of headache disorders in Europe: the Eurolight projectEur J Neurol201219570371122136117
   PubMed Web of Science ®Google Scholar
• GoldbergLDThe cost of migraine and its treatmentAm J Manag Care200511Suppl 2S62S6716095269
   PubMed Web of Science ®Google Scholar
• GoadsbyPJFerrariMDOlesenJEletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering CommitteeNeurology200054115616310636142
   PubMed Web of Science ®Google Scholar
• MathewNTSchoenenJWinnerPMuirheadNSikesCRComparative efficacy of eletriptan 40 mg versus sumatriptan 100 mgHeadache200343321422212603639
   PubMed Web of Science ®Google Scholar
• SandriniGFärkkiläMBurgessGForsterEHaughieSEletriptan Steering CommitteeEletriptan vs sumatriptan: a double-blind, placebo-controlled, multiple migraine attack studyNeurology20025981210121712391349
   PubMed Web of Science ®Google Scholar
• Garcia-RamosGMacGregorEAHilliardBBordiniCALestonJHettiarachchiJComparative efficacy of eletriptan vs naratriptan in the acute treatment of migraineCephalalgia200323986987614616928
   PubMed Web of Science ®Google Scholar
• SteinerTJDienerHCMacGregorEASchoenenJMuirheadsNSikesCRComparative efficacy of eletriptan and zolmitriptan in the acute treatment of migraineCephalalgia2003231094295214984226
   PubMed Web of Science ®Google Scholar
• FärkkiläMOlesenJDahlöfCEletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptanCephalalgia200323646347112807526
   PubMed Web of Science ®Google Scholar
• ChiaYCLimSHWangSJCheongYMDenaroJHettiarachchiJEfficacy of eletriptan in migraineurs with persistent poor response to nonsteroidal anti-inflammatory drugsHeadache200343998499014511275
   PubMed Web of Science ®Google Scholar
• DiamondMLHettiarachchiJHilliardBSandsGNettREffectiveness of eletriptan in acute migraine: primary care for Excedrin nonrespondersHeadache200444320921615012657
   PubMed Web of Science ®Google Scholar
• MartinVTLoderETaylorKAlmasMHilliardBEletriptan treatment of migraine in patients switching from barbiturate-containing analgesics: results from a multiple-attack studyCephalalgia200525972673416109055
   PubMed Web of Science ®Google Scholar
• FerrariMDGoadsbyPJRoonKILiptonRBTriptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trialsCephalalgia200222863365812383060
   PubMed Web of Science ®Google Scholar
• ThorlundKMillsEJWuPComparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysisCephalalgia201434425826724108308
   PubMed Web of Science ®Google Scholar
• Relpax (eletriptan hydrobromide) tablet, film coated [prescribing information]New York, NYPfizer Inc2013 Available from: http://labeling.pfizer.com/ShowLabeling.aspx?id=621Accessed July 31, 2014
   Google Scholar
• BelseyJDCost effectiveness of oral triptan therapy: a trans-national comparison based on a meta-analysis of randomised controlled trialsCurr Med Res Opin200420565966915140331
   PubMed Web of Science ®Google Scholar
• KelmanLVon SeggernRLUsing patient-centered endpoints to determine the cost-effectiveness of triptans for acute migraine therapyAm J Ther200613541141716988536
   PubMedGoogle Scholar
• MullinsCDSubediPRHealeyPJSanchezRJEconomic analysis of triptan therapy for acute migraine: a Medicaid perspectivePharmacotherapy20072781092110117655509
   PubMed Web of Science ®Google Scholar
• PerfettoEMWeisKAMullinsCDSubediPHealeyPJSrAn economic evaluation of triptan products for migraineValue Health20058664765516283865
   PubMed Web of Science ®Google Scholar
• SlofJBadiaXLainez-AndresJMGalvanJHerasJManagement costs of chest and CNS-related adverse events associated with the treatment of acute migraine attacks with oral triptansNeurologia2005206290298 Spanish16007512
   PubMed Web of Science ®Google Scholar
• WellsNHettiarachchiJDrummondMA cost-effectiveness analysis of eletriptan 40 and 80 mg versus sumatriptan 50 and 100 mg in the acute treatment of migraineValue Health20036443844712859585
   PubMed Web of Science ®Google Scholar
• RamsbergJHenrikssonMThe cost-effectiveness of oral triptan therapy in SwedenCephalalgia2007271546217212684
   PubMed Web of Science ®Google Scholar
• FerrariMDRoonKILiptonRBGoadsbyPJOral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trialsLancet200135892941668167511728541
   PubMed Web of Science ®Google Scholar
• OldmanADSmithLAMcQuayHJMooreRAPharmacological treatments for acute migraine: quantitative systematic reviewPain200297324725712044621
   PubMed Web of Science ®Google Scholar
• ThompsonMGawelMDesjardinsBFerkoNGrimaDAn economic evaluation of rizatriptan in the treatment of migrainePharmacoeconomics200523883785016097844
   PubMed Web of Science ®Google Scholar
• RamosELiuLMardekianJCabreraJIdentification of subpopulations of migraine patients who have a favorable cost profile with eletriptan treatmentCephalalgia2013338148149
   Google Scholar
• MembeSMcGahanLCimonKGawelMGiammarcoRMierzwinski-UrbanMTechnology Report: Triptans for Acute Migraine: Comparative Clinical Effectiveness and Cost-EffectivenessOttawa, ONCanadian Agency for Drugs and Technologies in Health2007 Available from: http://www.cadth.ca/media/pdf/I4001_tr_Triptans_e.pdfAccessed July 29, 2014
   Google Scholar
• DodickDWLiptonRBGoadsbyPJPredictors of migraine headache recurrence: a pooled analysis from the eletriptan databaseHeadache200848218419318234045
   PubMed Web of Science ®Google Scholar